New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients

Daniela Piga, Francesca Magri, Dario Ronchi, Stefania Paola Corti, Denise Alessandra Cassandrini, E. Mercuri, Giorgio Tasca, Enrico Silvio Bertini, Fabiana Fattori, Antonio Toscano, S. Messina, Isabella Moroni, Marina Mora, Maurizio Gualtiero Moggio, Irene Colombo, Teresa Giugliano, M. Pane, Chiara Fiorillo, Adele D'Amico, Claudio Bruno & 3 others Vincenzo Nigro, Nereo Bresolin, Giacomo Pietro Comi

Research output: Contribution to journalArticle

Abstract

Nemaline myopathy represents a group of clinically and genetically heterogeneous neuromuscular disorders. Different clinical-genetic entities have been characterized in the last few years, with implications for diagnostics and genetic counseling. Fifty percent of nemaline myopathy forms are due to NEB mutations, but genetic analysis of this large and complex gene by Sanger sequencing is time consuming and expensive. We selected 10 Italian patients with clinical and biopsy features suggestive for nemaline myopathy and negative for ACTA1, TPM2 and TPM3 mutations. We applied a targeted next-generation sequencing strategy designed to analyse NEB coding regions, the relative full introns and the promoter. We also evaluated copy number variations (by CGH array) and transcriptional changes by RNA Sanger sequencing, whenever possible. This combined strategy revealed 11 likely pathogenic variants in 8 of 10 patients. The molecular diagnosis was fully achieved in 3 of 8 patients, while only one heterozygous mutation was observed in 5 subjects. This approach revealed to be a fast and cost-effective way to analyse the large NEB gene in a small group of patients and might be promising for the detection of pathological variants of other genes featuring large coding regions and lacking mutational hotspots.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalJournal of Molecular Neuroscience
DOIs
Publication statusAccepted/In press - Apr 22 2016

Fingerprint

Nemaline Myopathies
Mutation
Genes
RNA Sequence Analysis
Genetic Counseling
Introns
Biopsy
Costs and Cost Analysis

Keywords

  • NEB mutations
  • Nemaline myopathy
  • Next-generation sequencing

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients. / Piga, Daniela; Magri, Francesca; Ronchi, Dario; Corti, Stefania Paola; Cassandrini, Denise Alessandra; Mercuri, E.; Tasca, Giorgio; Bertini, Enrico Silvio; Fattori, Fabiana; Toscano, Antonio; Messina, S.; Moroni, Isabella; Mora, Marina; Moggio, Maurizio Gualtiero; Colombo, Irene; Giugliano, Teresa; Pane, M.; Fiorillo, Chiara; D'Amico, Adele; Bruno, Claudio; Nigro, Vincenzo; Bresolin, Nereo; Comi, Giacomo Pietro.

In: Journal of Molecular Neuroscience, 22.04.2016, p. 1-9.

Research output: Contribution to journalArticle

Piga, D, Magri, F, Ronchi, D, Corti, SP, Cassandrini, DA, Mercuri, E, Tasca, G, Bertini, ES, Fattori, F, Toscano, A, Messina, S, Moroni, I, Mora, M, Moggio, MG, Colombo, I, Giugliano, T, Pane, M, Fiorillo, C, D'Amico, A, Bruno, C, Nigro, V, Bresolin, N & Comi, GP 2016, 'New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients', Journal of Molecular Neuroscience, pp. 1-9. https://doi.org/10.1007/s12031-016-0739-2
Piga, Daniela ; Magri, Francesca ; Ronchi, Dario ; Corti, Stefania Paola ; Cassandrini, Denise Alessandra ; Mercuri, E. ; Tasca, Giorgio ; Bertini, Enrico Silvio ; Fattori, Fabiana ; Toscano, Antonio ; Messina, S. ; Moroni, Isabella ; Mora, Marina ; Moggio, Maurizio Gualtiero ; Colombo, Irene ; Giugliano, Teresa ; Pane, M. ; Fiorillo, Chiara ; D'Amico, Adele ; Bruno, Claudio ; Nigro, Vincenzo ; Bresolin, Nereo ; Comi, Giacomo Pietro. / New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients. In: Journal of Molecular Neuroscience. 2016 ; pp. 1-9.
@article{d1f6b4822c7141bfae0350451fe4af17,
title = "New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients",
abstract = "Nemaline myopathy represents a group of clinically and genetically heterogeneous neuromuscular disorders. Different clinical-genetic entities have been characterized in the last few years, with implications for diagnostics and genetic counseling. Fifty percent of nemaline myopathy forms are due to NEB mutations, but genetic analysis of this large and complex gene by Sanger sequencing is time consuming and expensive. We selected 10 Italian patients with clinical and biopsy features suggestive for nemaline myopathy and negative for ACTA1, TPM2 and TPM3 mutations. We applied a targeted next-generation sequencing strategy designed to analyse NEB coding regions, the relative full introns and the promoter. We also evaluated copy number variations (by CGH array) and transcriptional changes by RNA Sanger sequencing, whenever possible. This combined strategy revealed 11 likely pathogenic variants in 8 of 10 patients. The molecular diagnosis was fully achieved in 3 of 8 patients, while only one heterozygous mutation was observed in 5 subjects. This approach revealed to be a fast and cost-effective way to analyse the large NEB gene in a small group of patients and might be promising for the detection of pathological variants of other genes featuring large coding regions and lacking mutational hotspots.",
keywords = "NEB mutations, Nemaline myopathy, Next-generation sequencing",
author = "Daniela Piga and Francesca Magri and Dario Ronchi and Corti, {Stefania Paola} and Cassandrini, {Denise Alessandra} and E. Mercuri and Giorgio Tasca and Bertini, {Enrico Silvio} and Fabiana Fattori and Antonio Toscano and S. Messina and Isabella Moroni and Marina Mora and Moggio, {Maurizio Gualtiero} and Irene Colombo and Teresa Giugliano and M. Pane and Chiara Fiorillo and Adele D'Amico and Claudio Bruno and Vincenzo Nigro and Nereo Bresolin and Comi, {Giacomo Pietro}",
year = "2016",
month = "4",
day = "22",
doi = "10.1007/s12031-016-0739-2",
language = "English",
pages = "1--9",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",

}

TY - JOUR

T1 - New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients

AU - Piga, Daniela

AU - Magri, Francesca

AU - Ronchi, Dario

AU - Corti, Stefania Paola

AU - Cassandrini, Denise Alessandra

AU - Mercuri, E.

AU - Tasca, Giorgio

AU - Bertini, Enrico Silvio

AU - Fattori, Fabiana

AU - Toscano, Antonio

AU - Messina, S.

AU - Moroni, Isabella

AU - Mora, Marina

AU - Moggio, Maurizio Gualtiero

AU - Colombo, Irene

AU - Giugliano, Teresa

AU - Pane, M.

AU - Fiorillo, Chiara

AU - D'Amico, Adele

AU - Bruno, Claudio

AU - Nigro, Vincenzo

AU - Bresolin, Nereo

AU - Comi, Giacomo Pietro

PY - 2016/4/22

Y1 - 2016/4/22

N2 - Nemaline myopathy represents a group of clinically and genetically heterogeneous neuromuscular disorders. Different clinical-genetic entities have been characterized in the last few years, with implications for diagnostics and genetic counseling. Fifty percent of nemaline myopathy forms are due to NEB mutations, but genetic analysis of this large and complex gene by Sanger sequencing is time consuming and expensive. We selected 10 Italian patients with clinical and biopsy features suggestive for nemaline myopathy and negative for ACTA1, TPM2 and TPM3 mutations. We applied a targeted next-generation sequencing strategy designed to analyse NEB coding regions, the relative full introns and the promoter. We also evaluated copy number variations (by CGH array) and transcriptional changes by RNA Sanger sequencing, whenever possible. This combined strategy revealed 11 likely pathogenic variants in 8 of 10 patients. The molecular diagnosis was fully achieved in 3 of 8 patients, while only one heterozygous mutation was observed in 5 subjects. This approach revealed to be a fast and cost-effective way to analyse the large NEB gene in a small group of patients and might be promising for the detection of pathological variants of other genes featuring large coding regions and lacking mutational hotspots.

AB - Nemaline myopathy represents a group of clinically and genetically heterogeneous neuromuscular disorders. Different clinical-genetic entities have been characterized in the last few years, with implications for diagnostics and genetic counseling. Fifty percent of nemaline myopathy forms are due to NEB mutations, but genetic analysis of this large and complex gene by Sanger sequencing is time consuming and expensive. We selected 10 Italian patients with clinical and biopsy features suggestive for nemaline myopathy and negative for ACTA1, TPM2 and TPM3 mutations. We applied a targeted next-generation sequencing strategy designed to analyse NEB coding regions, the relative full introns and the promoter. We also evaluated copy number variations (by CGH array) and transcriptional changes by RNA Sanger sequencing, whenever possible. This combined strategy revealed 11 likely pathogenic variants in 8 of 10 patients. The molecular diagnosis was fully achieved in 3 of 8 patients, while only one heterozygous mutation was observed in 5 subjects. This approach revealed to be a fast and cost-effective way to analyse the large NEB gene in a small group of patients and might be promising for the detection of pathological variants of other genes featuring large coding regions and lacking mutational hotspots.

KW - NEB mutations

KW - Nemaline myopathy

KW - Next-generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=84964273844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964273844&partnerID=8YFLogxK

U2 - 10.1007/s12031-016-0739-2

DO - 10.1007/s12031-016-0739-2

M3 - Article

SP - 1

EP - 9

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

ER -